ADVENZYMESBSEADVANCED ENZYME TECH LTD· Pharmaceuticals & BiotechnologyHighPositive
Announced Tue, 8 Sept, 2026 · 12:13 IST

Advanced Enzyme Technologies extinguishes 8.25 lakh shares from buyback

ADVENZYMES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹296.85
prior close
₹298.90
announcement price
In-mkt
timing
Nifty Microcap 250market+0.5%-0.4% vs market
Biotechnology peers, median of 5sector+0.7%-0.6% vs sector

On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.6 pts less than its Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.3
15m
+0.3
30m
+0.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1+0.5-0.4+0.7-0.6
Next day
+1.1+0.4+0.7-1.3+2.4
2d
+1.8+0.2+1.6-1.4+3.2
3d
-1.1+0.3-1.4+1.0-2.1
4d
-2.3-3.0+0.7+0.7-3.1
5d
-3.3-3.1-0.2-2.0-1.3
1w
-2.8-0.7-2.1-3.8+1.0
15d
-4.7-1.2-3.4——
1m
-10.3-4.2-6.1-6.4-3.9
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Biotechnology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advanced Enzyme Technologies has extinguished 8,25,028 equity shares (face value Rs. 2 each) that were bought back during August 2026 through the open market route via stock exchanges. This is part of the company's ongoing buyback programme first announced on August 10, 2026. Central Depository Services confirmed the debiting of these shares on September 2, 2026.

Likely market impact

Reduces outstanding share count, mildly boosting EPS. Signals ongoing capital return to shareholders.